202 related articles for article (PubMed ID: 37905690)
1. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
[TBL] [Abstract][Full Text] [Related]
2. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
3. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease.
Griñán-Ferré C; Codony S; Pujol E; Yang J; Leiva R; Escolano C; Puigoriol-Illamola D; Companys-Alemany J; Corpas R; Sanfeliu C; Pérez B; Loza MI; Brea J; Morisseau C; Hammock BD; Vázquez S; Pallàs M; Galdeano C
Neurotherapeutics; 2020 Oct; 17(4):1825-1835. PubMed ID: 32488482
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease.
Lee HT; Lee KI; Chen CH; Lee TS
J Neuroinflammation; 2019 Dec; 16(1):267. PubMed ID: 31847859
[TBL] [Abstract][Full Text] [Related]
6. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model.
Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y
J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration.
Bartra C; Irisarri A; Villoslada A; Corpas R; Aguirre S; García-Lara E; Suñol C; Pallàs M; Griñán-Ferré C; Sanfeliu C
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499477
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity.
Hung CC; Lee YH; Kuo YM; Hsu PC; Tsay HJ; Hsu YT; Lee CC; Liang JJ; Shie FS
J Neuroinflammation; 2019 Jun; 16(1):123. PubMed ID: 31176371
[TBL] [Abstract][Full Text] [Related]
9. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
11. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
[TBL] [Abstract][Full Text] [Related]
12. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
[TBL] [Abstract][Full Text] [Related]
13. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Faridar A; Vasquez M; Thome AD; Yin Z; Xuan H; Wang JH; Wen S; Li X; Thonhoff JR; Zhao W; Zhao H; Beers DR; Wong STC; Masdeu JC; Appel SH
Acta Neuropathol Commun; 2022 Sep; 10(1):144. PubMed ID: 36180898
[TBL] [Abstract][Full Text] [Related]
15. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.
Yang J; Bratt J; Franzi L; Liu JY; Zhang G; Zeki AA; Vogel CF; Williams K; Dong H; Lin Y; Hwang SH; Kenyon NJ; Hammock BD
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):46-55. PubMed ID: 24922186
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
